GALECTIN THERAPEUTICS INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
GALECTIN THERAPEUTICS INC. (GALT) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 58.31 million shares for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-08-16
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 58.31M shares, a 2.24% increase year-over-year.
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 57.13M shares, a 0.31% increase year-over-year.
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 57.08M shares, a 34.39% increase year-over-year.
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 57.05M shares, a 0.73% increase year-over-year.
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 57.03M shares, a 9.17% increase from fiscal 2019.
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 52.24M shares, a 32.54% increase from fiscal 2018.
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 39.41M shares, a 10.96% increase from fiscal 2017.
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 35.52M shares, a 21.58% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-06-30 | 58.31M shares 10-Q · filed 2021-08-16 | 57.73M shares 10-Q · filed 2021-08-16 | 57.51M shares derived: average of 3 quarters · filed 2021-08-16 | 57.39M shares derived: average of 4 quarters · filed 2021-08-16 |
| 2021-03-31 | 57.13M shares 10-Q · filed 2021-05-17 | 57.10M shares derived: average of 2 quarters · filed 2021-05-17 | 57.09M shares derived: average of 3 quarters · filed 2021-05-17 | 57.07M shares derived: average of 4 quarters · filed 2021-08-16 |
| 2020-12-31 | 57.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | 57.06M shares derived: average of 2 quarters · filed 2021-03-31 | 57.05M shares derived: average of 3 quarters · filed 2021-08-16 | 57.03M shares 10-K · filed 2021-03-31 |
| 2020-09-30 | 57.05M shares 10-Q · filed 2020-11-09 | 57.04M shares derived: average of 2 quarters · filed 2021-08-16 | 57.01M shares 10-Q · filed 2020-11-09 | 53.38M shares derived: average of 4 quarters · filed 2021-08-16 |
| 2020-06-30 | 57.03M shares 10-Q · filed 2021-08-16 | 56.99M shares 10-Q · filed 2021-08-16 | 52.15M shares derived: average of 3 quarters · filed 2021-08-16 | 53.27M shares derived: average of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | 56.96M shares 10-Q · filed 2021-05-17 | 49.71M shares derived: average of 2 quarters · filed 2021-05-17 | 52.02M shares derived: average of 3 quarters · filed 2021-05-17 | 51.59M shares derived: average of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | 42.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | 49.55M shares derived: average of 2 quarters · filed 2021-03-31 | 49.80M shares derived: average of 3 quarters · filed 2021-03-31 | 52.24M shares 10-K · filed 2021-03-31 |
| 2019-09-30 | 56.63M shares 10-Q · filed 2020-11-09 | 53.47M shares derived: average of 2 quarters · filed 2020-11-09 | 55.49M shares 10-Q · filed 2020-11-09 | 48.27M shares derived: average of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | 50.30M shares 10-Q · filed 2020-08-10 | 47.65M shares 10-Q · filed 2020-08-10 | 45.49M shares derived: average of 3 quarters · filed 2020-08-10 | 44.35M shares derived: average of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | 44.98M shares 10-Q · filed 2020-05-11 | 43.08M shares derived: average of 2 quarters · filed 2020-05-11 | 42.36M shares derived: average of 3 quarters · filed 2020-05-11 | 41.33M shares derived: average of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | 41.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 41.06M shares derived: average of 2 quarters · filed 2020-03-16 | 40.11M shares derived: average of 3 quarters · filed 2020-03-16 | 39.41M shares 10-K · filed 2020-03-16 |
| 2018-09-30 | 40.92M shares 10-Q · filed 2019-11-12 | 39.57M shares derived: average of 2 quarters · filed 2019-11-12 | 38.82M shares 10-Q · filed 2019-11-12 | 38.68M shares derived: average of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | 38.23M shares 10-Q · filed 2019-08-09 | 37.76M shares 10-Q · filed 2019-08-09 | 37.93M shares derived: average of 3 quarters · filed 2019-08-09 | 37.24M shares derived: average of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | 37.28M shares 10-Q · filed 2019-05-10 | 37.78M shares derived: average of 2 quarters · filed 2019-05-10 | 36.91M shares derived: average of 3 quarters · filed 2019-05-10 | 36.36M shares derived: average of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | 38.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | 36.72M shares derived: average of 2 quarters · filed 2019-03-06 | 36.05M shares derived: average of 3 quarters · filed 2019-03-06 | 35.52M shares 10-K · filed 2019-03-06 |
| 2017-09-30 | 35.16M shares 10-Q · filed 2018-11-13 | 34.93M shares derived: average of 2 quarters · filed 2018-11-13 | 34.60M shares 10-Q · filed 2018-11-13 | 33.38M shares derived: average of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | 34.69M shares 10-Q · filed 2018-08-14 | 34.31M shares 10-Q · filed 2018-08-14 | 32.78M shares derived: average of 3 quarters · filed 2018-08-14 | 31.91M shares derived: average of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | 33.93M shares 10-Q · filed 2018-05-11 | 31.83M shares derived: average of 2 quarters · filed 2018-05-11 | 30.98M shares derived: average of 3 quarters · filed 2018-05-11 | 30.49M shares derived: average of 4 quarters · filed 2018-05-11 |
| 2016-12-31 | 29.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | 29.51M shares derived: average of 2 quarters · filed 2018-03-29 | 29.34M shares derived: average of 3 quarters · filed 2018-03-29 | 29.22M shares 10-K · filed 2018-03-29 |
| 2016-09-30 | 29.28M shares 10-Q · filed 2017-11-07 | 29.15M shares derived: average of 2 quarters · filed 2017-11-07 | 29.05M shares 10-Q · filed 2017-11-07 | 28.25M shares derived: average of 4 quarters · filed 2017-11-07 |
| 2016-06-30 | 29.02M shares 10-Q · filed 2017-08-14 | 29.00M shares 10-Q · filed 2017-08-14 | 27.91M shares derived: average of 3 quarters · filed 2017-08-14 | 26.88M shares derived: average of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | 28.83M shares 10-Q · filed 2017-05-15 | 27.36M shares derived: average of 2 quarters · filed 2017-05-15 | 26.17M shares derived: average of 3 quarters · filed 2017-05-15 | 25.56M shares derived: average of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | 25.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28 | 24.84M shares derived: average of 2 quarters · filed 2017-03-28 | 24.47M shares derived: average of 3 quarters · filed 2017-03-28 | 24.12M shares 10-K · filed 2017-03-28 |
| 2015-09-30 | 23.79M shares 10-Q · filed 2016-11-08 | 23.76M shares derived: average of 2 quarters · filed 2016-11-08 | 23.53M shares 10-Q · filed 2016-11-08 | 23.20M shares derived: average of 4 quarters · filed 2016-11-08 |
| 2015-06-30 | 23.73M shares 10-Q · filed 2016-08-09 | 23.40M shares 10-Q · filed 2016-08-09 | 23.00M shares derived: average of 3 quarters · filed 2016-08-09 | 22.76M shares derived: average of 4 quarters · filed 2016-08-09 |
| 2015-03-31 | 23.06M shares 10-Q · filed 2016-05-10 | 22.63M shares derived: average of 2 quarters · filed 2016-05-10 | 22.44M shares derived: average of 3 quarters · filed 2016-05-10 | 22.32M shares derived: average of 4 quarters · filed 2016-05-10 |
| 2014-12-31 | 22.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | 22.13M shares derived: average of 2 quarters · filed 2016-03-15 | 22.08M shares derived: average of 3 quarters · filed 2016-03-15 | 21.85M shares 10-K · filed 2016-03-15 |
| 2014-09-30 | 22.05M shares 10-Q · filed 2015-11-09 | 22.02M shares derived: average of 2 quarters · filed 2015-11-09 | 21.73M shares 10-Q · filed 2015-11-09 | 20.62M shares derived: average of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | 21.98M shares 10-Q · filed 2015-08-10 | 21.57M shares 10-Q · filed 2015-08-10 | 20.14M shares derived: average of 3 quarters · filed 2016-03-15 | 19.36M shares derived: average of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | 20.27M shares 10-Q · filed 2015-05-11 | 19.23M shares derived: average of 2 quarters · filed 2016-03-15 | 18.48M shares derived: average of 3 quarters · filed 2016-03-15 | 17.92M shares derived: average of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | 18.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | 17.59M shares derived: average of 2 quarters · filed 2016-03-15 | 17.14M shares derived: average of 3 quarters · filed 2016-03-15 | 16.87M shares 10-K · filed 2016-03-15 |
| 2013-09-30 | 16.99M shares 10-Q · filed 2014-11-10 | 16.61M shares derived: average of 2 quarters · filed 2014-11-10 | 16.44M shares 10-Q · filed 2014-11-10 | 16.32M shares derived: average of 4 quarters · filed 2015-03-18 |
| 2013-06-30 | 16.24M shares 10-Q · filed 2013-08-14 | 16.16M shares 10-Q · filed 2014-08-07 | 16.10M shares derived: average of 3 quarters · filed 2015-03-18 | 16.03M shares derived: average of 4 quarters · filed 2015-03-18 |
| 2013-03-31 | 16.08M shares 10-Q · filed 2014-05-13 | 16.02M shares derived: average of 2 quarters · filed 2015-03-18 | 15.96M shares derived: average of 3 quarters · filed 2015-03-18 | 15.90M shares derived: average of 4 quarters · filed 2015-03-18 |
| 2012-12-31 | 15.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | 15.90M shares derived: average of 2 quarters · filed 2015-03-18 | 15.83M shares derived: average of 3 quarters · filed 2015-03-18 | 15.13M shares 10-K · filed 2015-03-18 |
| 2012-09-30 | 15.82M shares 10-Q · filed 2013-11-12 | 15.77M shares derived: average of 2 quarters · filed 2013-11-12 | 14.85M shares 10-Q · filed 2013-11-12 | 14.35M shares derived: average of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | 15.71M shares 10-Q · filed 2013-08-14 | 14.36M shares 10-Q · filed 2013-08-14 | 13.86M shares derived: average of 3 quarters · filed 2013-08-14 | 13.48M shares derived: average of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | 13.01M shares 10-Q · filed 2013-05-10 | 12.93M shares derived: average of 2 quarters · filed 2013-05-10 | 12.74M shares derived: average of 3 quarters · filed 2013-05-10 | 12.45M shares derived: average of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | 12.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | 12.60M shares derived: average of 2 quarters · filed 2013-03-29 | 12.27M shares derived: average of 3 quarters · filed 2013-03-29 | 11.99M shares 10-K · filed 2013-03-29 |
| 2011-09-30 | 12.35M shares 10-Q · filed 2012-11-09 | 11.97M shares derived: average of 2 quarters · filed 2012-11-09 | 11.70M shares 10-Q · filed 2012-11-09 | |
| 2011-06-30 | 11.59M shares 10-Q · filed 2012-08-10 | 11.37M shares 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |